Lysostaphin Treatment of Experimental Aortic Valve Endocarditis Caused by a Staphylococcus aureus Isolate with Reduced Susceptibility to Vancomycin

The rabbit model of endocarditis was used to test the effectiveness of vancomycin and two different lysostaphin dosing regimens for the treatment of infections caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin (glycopeptide-intermediate susceptible S. aureus [GISA])....

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Patron, Roberto L., Climo, Michael W., Goldstein, Beth P., Archer, Gordon L.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89356/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10390235/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.7.1754
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!